Transitioning molecular imaging from a preclinical technique to a standard clinical tool could help detect the very earliest stages of disease, reports Tami Freeman Tools of the trade Left: this ...

The new imaging system, a noninvasive technology, analyzes the expression of a protein in pigmented lesions that correlates with tumor development. The system accurately discerned the difference ...

A new molecular imaging agent can accurately identify a crucial biomarker found among many different types of cancer. Precise visualization of the trophoblast cell surface antigen 2 (Trop2) biomarker ...

A molecular image showing the major components of a spinal column. Cells are colored in yellow (grey matter), blue (white matter), teal (fluid), green (blood vessel), pink (bone/bone marrow) and red ...

Screening women with dense breasts with both molecular breast imaging (MBI) and digital breast tomosynthesis (DBT) increased overall invasive cancer detection while modestly increasing the recall rate ...

BERLIN & NAPLES, Fla.--(BUSINESS WIRE)--Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on ...

Kimberly Kelly, professor of biomedical engineering at the University of Virginia School of Engineering and Applied Science and the UVA School of Medicine, has been named editor-in-chief of the ...

The Case Comprehensive Cancer Center will host its next seminar series event Friday, Feb. 2, from noon to 1 p.m. in the Iris S. and Bert L. Wolstein Research Building auditorium. The event will ...

Approval marks a major milestone in reducing gadolinium exposure while maintaining diagnostic performance, aligning with clinical guidance to use the lowest effective dose MONTREAL, April 17, 2026 ...